{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:25:34Z","timestamp":1790281534842,"version":"4.1.0"},"reference-count":27,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_182690"],"award-info":[{"award-number":["320030_182690"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_182690"],"award-info":[{"award-number":["320030_182690"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>This editorial aims to synthesize the eleven papers that have contributed to this special issue, where the mechanisms of mesothelioma heterogeneity have been tackled from different angles.<\/jats:p>","DOI":"10.3390\/ijms19113560","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T02:42:41Z","timestamp":1542163361000},"page":"3560","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Special Issue on Mechanisms of Mesothelioma Heterogeneity: Highlights and Open Questions"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-0294","authenticated-orcid":false,"given":"Emanuela","family":"Felley-Bosco","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Oncology, University Hospital Zurich, Sternwartstrasse 14, 8091 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tolani, B., Acevedo, L.A., Hoang, N.T., and He, B. (2018). Heterogeneous contributing factors in mpm disease development and progression: Biological advances and clinical implications. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010238"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Oehl, K., Vrugt, B., Opitz, I., and Meerang, M. (2018). Heterogeneity in malignant pleural mesothelioma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061603"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sarun, K.H., Lee, K., Williams, M., Wright, C.M., Clarke, C.J., Cheng, N.C., Takahashi, K., and Cheng, Y.Y. (2018). Genomic deletion of BAP1 and CDKN2A are useful markers for quality control of malignant pleural mesothelioma (MPM) primary cultures. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103056"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Serio, G., Pezzuto, F., Marzullo, A., Scattone, A., Cavone, D., Punzi, A., Fortarezza, F., Gentile, M., Buonadonna, A.L., and Barbareschi, M. (2017). Peritoneal mesothelioma with residential asbestos exposure. Report of a case with long survival (seventeen years) analyzed by Cgh-array. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081818"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sato, T., and Sekido, Y. (2018). Nf2\/merlin inactivation and potential therapeutic targets in mesothelioma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19040988"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hagenbeek, T.J., Webster, J.D., Kljavin, N.M., Chang, M.T., Pham, T., Lee, H.J., Klijn, C., Cai, A.G., Totpal, K., and Ravishankar, B. (2018). The hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors. Sci. Signal, 11.","DOI":"10.1126\/scisignal.aaj1757"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41388-018-0153-z","article-title":"How asbestos drives the tissue towards tumors: Yap activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations","volume":"37","author":"Rehrauer","year":"2018","journal-title":"Oncogene"},{"key":"ref_8","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Sekido","year":"1995","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng0294-185","article-title":"Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types","volume":"6","author":"Bianchi","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline bap1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hmeljak, J., Sanchez-Vega, F., Hoadley, K.A., Shih, J., Stewart, C., Heiman, D.I., Tarpey, P., Danilova, L., Drill, E., and Gibb, E.A. (2018). Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov.","DOI":"10.1158\/2159-8290.CD-18-0804"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-981-10-5203-3_7","article-title":"Long noncoding RNAS in cancer and therapeutic potential","volume":"1008","author":"Renganathan","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Singh, A.S., Heery, R., and Gray, S.G. (2018). In silico and in vitro analyses of lncRNAs as potential regulators in the transition from the epithelioid to sarcomatoid histotype of malignant pleural mesothelioma (MPM). Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051297"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Felley-Bosco, E., and Rehrauer, H. (2018). Non-coding transcript heterogeneity in mesothelioma: Insights from asbestos-exposed mice. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041163"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Martinez-Rivera, V., Negrete-Garcia, M.C., Avila-Moreno, F., and Ortiz-Quintero, B. (2018). Secreted and tissue mirnas as diagnosis biomarkers of malignant pleural mesothelioma. Int. J. Mol. Sci.","DOI":"10.3390\/ijms19020595"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/nar\/gkx082","article-title":"Knowledge about the presence or absence of miRNA isoforms (isomirs) can successfully discriminate amongst 32 tcga cancer types","volume":"45","author":"Telonis","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jtho.2016.12.019","article-title":"Bap1 is altered by copy number loss, mutation, and\/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas","volume":"12","author":"Leblay","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Garg, A.D., More, S., Rufo, N., Mece, O., Sassano, M.L., Agostinis, P., Zitvogel, L., Kroemer, G., and Galluzzi, L. (2017). Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology, 6.","DOI":"10.1080\/2162402X.2017.1386829"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Minnema-Luiting, J., Vroman, H., Aerts, J., and Cornelissen, R. (2018). Heterogeneity in immune cell content in malignant pleural mesothelioma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041041"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (keynote-028): Preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of yap\/taz in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Jean, D., and Jaurand, M.C. (2018). Mesotheliomas in genetically engineered mice unravel mechanism of mesothelial carcinogenesis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082191"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Colin, D.J., Cottet-Dumoulin, D., Faivre, A., Germain, S., Triponez, F., and Serre-Beinier, V. (2018). Experimental model of human malignant mesothelioma in athymic mice. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071881"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/11\/3560\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:29:10Z","timestamp":1760196550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/11\/3560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["ijms19113560"],"URL":"https:\/\/doi.org\/10.3390\/ijms19113560","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]}}}